4D Molecular Therapeutics, Inc. (FDMT)
NASDAQ: FDMT · Real-Time Price · USD
8.21
-0.30 (-3.53%)
At close: Oct 24, 2024, 4:00 PM
8.05
-0.16 (-1.95%)
After-hours: Oct 24, 2024, 4:39 PM EDT
4D Molecular Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Oct '24 Oct 24, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 427 | 866 | 719 | 705 | 1,098 | - | |
| Market Cap Growth | 43.47% | 20.40% | 2.03% | -35.79% | - | - | |
| Enterprise Value | -122 | 562 | 497 | 478 | 1,185 | - | |
| Last Close Price | 8.51 | 20.26 | 22.21 | 21.94 | 41.45 | - | |
| PE Ratio | - | -7.86 | -6.68 | -8.53 | -4.70 | - | |
| PS Ratio | 19.97 | 41.80 | 229.92 | 39.09 | 80.68 | - | |
| PB Ratio | 0.75 | 2.81 | 3.11 | 2.21 | 4.28 | - | |
| P/FCF Ratio | -12.45 | -11.03 | -7.32 | -9.01 | -21.16 | - | |
| P/OCF Ratio | -12.74 | -11.43 | -8.30 | -10.20 | -21.57 | - | |
| EV/Sales Ratio | 25.25 | 27.10 | 158.88 | 26.50 | 87.05 | - | |
| EV/EBITDA Ratio | -4.03 | -5.17 | -4.62 | -6.85 | -21.46 | - | |
| EV/EBIT Ratio | -3.89 | -4.98 | -4.52 | -6.70 | -20.91 | - | |
| EV/FCF Ratio | -5.86 | -7.15 | -5.06 | -6.11 | -22.83 | - | |
| Debt / Equity Ratio | 0.02 | 0.05 | 0.07 | 0.05 | - | - | |
| Debt / FCF Ratio | -0.16 | -0.19 | -0.16 | -0.21 | - | - | |
| Asset Turnover | 0.04 | 0.07 | 0.01 | 0.06 | 0.08 | 0.09 | |
| Quick Ratio | 27.93 | 15.21 | 13.58 | 15.21 | 16.62 | 3.91 | |
| Current Ratio | 28.48 | 15.65 | 14.02 | 15.69 | 16.88 | 4.05 | |
| Return on Equity (ROE) | -24.06% | -37.40% | -39.06% | -24.78% | -39.59% | -93.56% | |
| Return on Assets (ROA) | -16.86% | -23.45% | -22.35% | -13.89% | -20.44% | -36.75% | |
| Return on Capital (ROIC) | -17.40% | -24.75% | -23.59% | -15.06% | -24.73% | -54.11% | |
| Earnings Yield | -24.85% | -11.64% | -14.94% | -10.11% | -5.16% | - | |
| FCF Yield | -19.71% | -9.07% | -13.65% | -11.10% | -4.73% | - | |
| Buyback Yield / Dilution | -39.32% | -20.95% | -16.66% | -331.23% | -25.05% | -1.85% | |
| Total Shareholder Return | -39.32% | -20.95% | -16.66% | -331.23% | -25.05% | -1.85% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.